Newsroom
Sorted by: Latest
-
Dominion Energy Schedules Fourth-Quarter 2025 Earnings Call
RICHMOND, Va.--(BUSINESS WIRE)--Dominion Energy (NYSE: D) will host its fourth-quarter 2025 earnings call at 11 a.m. ET on Monday, Feb. 23, 2026. Management will discuss matters of interest to financial and other stakeholders including recent financial results. A live webcast of the conference call, including accompanying slides and other financial information, will be available on the investor information pages at investors.dominionenergy.com. For individuals who prefer to join via telephone,...
-
NRG Energy Announces Leadership Succession Plan
HOUSTON--(BUSINESS WIRE)--NRG Energy, Inc. (NYSE: NRG) today announced that its Board of Directors has appointed Robert J. Gaudette, Executive Vice President, President of NRG Business and Wholesale Operations, as Chief Executive Officer, effective April 30, 2026, the date of the Company’s 2026 Annual Meeting of Stockholders. In connection with his appointment as CEO, the Board has named Mr. Gaudette President of NRG, effective today. The Board also plans to nominate Mr. Gaudette for election t...
-
ATL Partners Acquires SkyMark and Rampmaster to Create a Leading Specialty Vehicle Equipment Platform Serving the Aviation and Transportation-Related End Markets
NEW YORK--(BUSINESS WIRE)--ATL Partners (“ATL”), a middle-market private equity firm focused on commercial aerospace, national security, and transportation & logistics sectors, today announced the acquisitions of SkyMark Companies (“SkyMark”), a leading manufacturer of aircraft refueling trucks and hydrant dispensers as well as other transportation-related specialty vehicles, and Rampmaster, a premier designer and manufacturer of aircraft refueling solutions for commercial and general aviat...
-
Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO® (plozasiran) for Familial Chylomicronemia Syndrome (FCS) in China
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the Chinese National Medical Products Administration (NMPA) has approved REDEMPLO® (plozasiran) for the reduction of triglyceride levels in adult patients with familial chylomicronemia syndrome (FCS). FCS is a severe, rare disease characterized by triglyceride levels that can be 10 to 100 times higher than normal leading to a substantially higher risk of developing acute, recurrent, and potent...
-
CoStar Group Provides Full Year 2026 and Medium-Term Outlook with Significant Adjusted EBITDA Expansion
ARLINGTON, Va.--(BUSINESS WIRE)--CoStar Group, Inc. (NASDAQ: CSGP), a leading provider of online real estate marketplaces, information, analytics, and 3D digital twin technology in the property markets, today provided an update on key business, financial, and corporate governance initiatives for 2026 and beyond, which have all been unanimously approved by the Company’s Board of Directors and its Capital Allocation Committee. As a result of a robust review undertaken by the Capital Allocation Co...
-
Albertsons® Companies, Inc. Reports Third Quarter Fiscal 2025 Results
BOISE, Idaho--(BUSINESS WIRE)--Albertsons® Companies, Inc. today reported results for the third quarter of fiscal 2025, which ended November 29, 2025....
-
XCharge North America and Energy Plus Partner to Build One of the Largest Battery-Backed EV Charging Depots in the U.S.
KYLE, Texas--(BUSINESS WIRE)--XCharge North America (“XCharge NA”), the North American subsidiary of XCHG Limited (NASDAQ: XCH, “XCharge”) and provider of high-power EV charging and battery-integrated solutions designed to strengthen the North American electrical grid, announced today that it has partnered with Energy Plus, a leading New York–based energy-efficiency and electrification contractor, to transform New York’s EV charging landscape. Slated to go live in Q2 2026, the new site in Willi...
-
Nuevocor Appoints Al Gianchetti as Chief Executive Officer
SINGAPORE & PARIS & PHILADELPHIA--(BUSINESS WIRE)--Nuevocor, a global biotechnology company, today announced the appointment of Al Gianchetti as Chief Executive Officer (CEO) and member of the Board of Directors. Nuevocor develops novel therapies for patients suffering from life-threatening cardiomyopathies, who currently have no effective treatments. Nuevocor’s science addresses the underlying aberrant mechanobiology that drives the progress of disease. Al Gianchetti’s deep expertise in cardio...
-
Valvoline Instant Oil Change Breaks Records as It Raises $1.8 Million for Children’s Miracle Network Hospitals
LEXINGTON, Ky.--(BUSINESS WIRE)--Valvoline Inc. (NYSE: VVV), the quick, easy, trusted leader in preventive automotive maintenance, today announced that its company and participating franchise Valvoline Instant Oil Change and Great Canadian Oil Change service centers raised more than $1.8 million, a nearly 40% increase over what the company raised in 2025. Funds were raised through guest donations at the time of service, corporate-led fundraising efforts, and contributions from Valvoline Instant...
-
Superior Health Holdings Expands Louisiana Hospice Footprint with Acquisition of Hope Healthcare & Hospice (Bayou Country)
BATON ROUGE, La.--(BUSINESS WIRE)--Superior Health Holdings (“Superior”), a leading provider of home health and hospice services across Louisiana, today announced the acquisition of the Bayou Country hospice operations of Hope Healthcare and Hospice BC, LLC ("Hope Hospice"), a community-based hospice provider headquartered in Houma, Louisiana. This acquisition expands Superior’s integrated care capabilities and deepens its presence in Southern Louisiana. Hope Hospice serves a broad area through...